1. Home
  2. HPS vs NPCE Comparison

HPS vs NPCE Comparison

Compare HPS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Preferred Income Fund III Preferred Income Fund III

HPS

John Hancock Preferred Income Fund III Preferred Income Fund III

HOLD

Current Price

$14.36

Market Cap

473.3M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.39

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPS
NPCE
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.3M
432.3M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
HPS
NPCE
Price
$14.36
$15.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
72.9K
170.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$13.80
$7.56
52 Week High
$15.68
$18.97

Technical Indicators

Market Signals
Indicator
HPS
NPCE
Relative Strength Index (RSI) 49.51 62.42
Support Level $13.92 $15.25
Resistance Level $14.75 $15.71
Average True Range (ATR) 0.26 0.68
MACD 0.03 0.21
Stochastic Oscillator 59.63 95.38

Price Performance

Historical Comparison
HPS
NPCE

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: